Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

My interpretation is that the FDA would have to at least approve Brilacidin for use in one anti-bacterial indication before they could complete the contract which makes sense. The large pharma wouldn't sign a deal for an unapproved anti-bacterial agent that they couldn't use in conjunction with their medical devices/implants. Timeframe to completion of the contract, IMO, would be correlated to the FDA approval of Brilacidin after a successful Phase 3 ABSSSI trial...2016 most likely.